Synchron opens a patient registry ahead of a larger Stentrode trial

Synchron/Stentrode BCI

Synchron launched a patient registry for the Stentrode endovascular brain-computer interface, inviting patients, carers and clinicians to register interest ahead of a larger, later-stage clinical trial. The registry aims to maintain engagement with potential users while the company scales up from early feasibility studies to broader efficacy testing.

• Registry opens enrollment ahead of expanded Stentrode trial; targets people with severe paralysis who might benefit from BCI restoration of communication and device control.
• Stentrode placed via minimally invasive endovascular procedure; positioned on motor cortex surface via blood vessel access; no open brain surgery required.
• Registry facilitates participant recruitment and relationship-building as Synchron transitions from early safety data (COMMAND study) toward larger efficacy trials.